{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:01:15Z","timestamp":1793228475465,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10620-019-05841-x","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T15:02:46Z","timestamp":1568646166000},"page":"376-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-7386","authenticated-orcid":false,"given":"Shaun S. C.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline I.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"key":"5841_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.177.4043.56","volume":"177","author":"RK Ockner","year":"1972","unstructured":"Ockner RK, Manning JA, Poppenhausen RB, Ho WK. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science.. 1972;177:56\u201358.","journal-title":"Science."},{"key":"5841_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF03194597","volume":"47","author":"A Chmurzynska","year":"2006","unstructured":"Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet.. 2006;47:39\u201348. \nhttps:\/\/doi.org\/10.1007\/BF03194597\n\n.","journal-title":"J Appl Genet."},{"key":"5841_CR3","doi-asserted-by":"publisher","first-page":"32679","DOI":"10.1074\/jbc.R110.135210","volume":"285","author":"J Storch","year":"2010","unstructured":"Storch J, Thumser AE. Tissue-specific functions in the fatty acid-binding protein family. The Journal of biological Chem.. 2010;285:32679\u201332683. \nhttps:\/\/doi.org\/10.1074\/jbc.R110.135210\n\n.","journal-title":"The Journal of biological Chem."},{"key":"5841_CR4","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.bbalip.2017.09.006","volume":"1862","author":"L Rodriguez Sawicki","year":"2017","unstructured":"Rodriguez Sawicki L, Bottasso Arias NM, Scaglia N, et al. FABP1 knockdown in human enterocytes impairs proliferation and alters lipid metabolism. Biochim Biophys Acta Mol Cell Biol Lipids.. 2017;1862:1587\u20131594. \nhttps:\/\/doi.org\/10.1016\/j.bbalip.2017.09.006\n\n.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"key":"5841_CR5","doi-asserted-by":"publisher","first-page":"G803","DOI":"10.1152\/ajpgi.00229.2010","volume":"300","author":"WS Lagakos","year":"2011","unstructured":"Lagakos WS, Gajda AM, Agellon L, et al. Different functions of intestinal and liver-type fatty acid-binding proteins in intestine and in whole body energy homeostasis. Am J Physiol Gastrointest Liver Physiol.. 2011;300:G803\u2013G814. \nhttps:\/\/doi.org\/10.1152\/ajpgi.00229.2010\n\n.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"5841_CR6","doi-asserted-by":"publisher","first-page":"738563","DOI":"10.1155\/2015\/738563","volume":"2015","author":"NM Bottasso Arias","year":"2015","unstructured":"Bottasso Arias NM, Garcia M, Bondar C, et al. Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy. Mediators Inflamm.. 2015;2015:738563. \nhttps:\/\/doi.org\/10.1155\/2015\/738563\n\n.","journal-title":"Mediators Inflamm."},{"key":"5841_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/MCG.0b013e31819194b0","volume":"43","author":"JP Derikx","year":"2009","unstructured":"Derikx JP, Vreugdenhil AC, Van den Neucker AM, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol.. 2009;43:727\u2013733. \nhttps:\/\/doi.org\/10.1097\/MCG.0b013e31819194b0\n\n.","journal-title":"J Clin Gastroenterol."},{"key":"5841_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0009-9120%2803%2900096-1","volume":"36","author":"MMAL Pelsers","year":"2003","unstructured":"Pelsers MMAL, Namiot Z, Kisielewski W, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem.. 2003;36:529\u2013535. \nhttps:\/\/doi.org\/10.1016\/S0009-9120%2803%2900096-1\n\n.","journal-title":"Clin Biochem."},{"key":"5841_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","volume":"7","author":"M Furuhashi","year":"2008","unstructured":"Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov.. 2008;7:489\u2013503. \nhttps:\/\/doi.org\/10.1038\/nrd2589\n\n.","journal-title":"Nat Rev Drug Discov."},{"key":"5841_CR10","doi-asserted-by":"publisher","first-page":"e50810","DOI":"10.1371\/journal.pone.0050810","volume":"7","author":"D Praslickova","year":"2012","unstructured":"Praslickova D, Torchia EC, Sugiyama MG, et al. The ileal lipid binding protein is required for efficient absorption and transport of bile acids in the distal portion of the murine small intestine. PLoS One.. 2012;7:e50810. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0050810\n\n.","journal-title":"PLoS One."},{"key":"5841_CR11","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00268-007-9182-4","volume":"31","author":"MC van de Poll","year":"2007","unstructured":"van de Poll MC, Derikx JP, Buurman WA, et al. Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection. World J Surg.. 2007;31:2033\u20132038. \nhttps:\/\/doi.org\/10.1007\/s00268-007-9182-4\n\n.","journal-title":"World J Surg."},{"key":"5841_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MCO.0000000000000031","volume":"17","author":"AE Thumser","year":"2014","unstructured":"Thumser AE, Moore JB, Plant NJ. Fatty acid binding proteins: tissue-specific functions in health and disease. Curr Opin Clin Nutr Metab Care.. 2014;17:124\u2013129. \nhttps:\/\/doi.org\/10.1097\/MCO.0000000000000031\n\n.","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"5841_CR13","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1194\/jlr.R056705","volume":"56","author":"G Wang","year":"2015","unstructured":"Wang G, Bonkovsky HL, de Lemos A, Burczynski FJ. Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res.. 2015;56:2238\u20132247. \nhttps:\/\/doi.org\/10.1194\/jlr.R056705\n\n.","journal-title":"J Lipid Res."},{"key":"5841_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0140-6736(06)69525-1","volume":"368","author":"PW Lin","year":"2006","unstructured":"Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet.. 2006;368:1271\u20131283. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(06)69525-1\n\n.","journal-title":"Lancet."},{"key":"5841_CR15","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1136\/fn.88.1.F11","volume":"88","author":"W McGuire","year":"2003","unstructured":"McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed.. 2003;88:F11\u2013F14.","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"5841_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1084-2756(03)00123-4","volume":"8","author":"JS Lee","year":"2003","unstructured":"Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol.. 2003;8:449\u2013459. \nhttps:\/\/doi.org\/10.1016\/S1084-2756(03)00123-4\n\n.","journal-title":"Semin Neonatol."},{"key":"5841_CR17","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s12098-016-2144-9","volume":"83","author":"G Yang","year":"2016","unstructured":"Yang G, Wang Y, Jiang X. Diagnostic value of intestinal fatty-acid-binding protein in necrotizing enterocolitis: a systematic review and meta-analysis. Indian J Pediatr.. 2016;83:1410\u20131419. \nhttps:\/\/doi.org\/10.1007\/s12098-016-2144-9\n\n.","journal-title":"Indian J Pediatr."},{"key":"5841_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12519-015-0035-1","volume":"12","author":"Y Liu","year":"2016","unstructured":"Liu Y, Jiang L-F, Zhang R-P, Zhang W-T. Clinical significance of FABP2 expression in newborns with necrotizing enterocolitis. World J Pediatr WJP.. 2016;12:159\u2013165. \nhttps:\/\/doi.org\/10.1007\/s12519-015-0035-1\n\n.","journal-title":"World J Pediatr WJP."},{"key":"5841_CR19","doi-asserted-by":"publisher","first-page":"156704","DOI":"10.1155\/2015\/156704","volume":"2015","author":"S Cheng","year":"2015","unstructured":"Cheng S, Yu J, Zhou M, Tu Y, Lu Q. Serologic intestinal-fatty acid binding protein in necrotizing enterocolitis diagnosis: a meta-analysis. BioMed Res Int.. 2015;2015:156704. \nhttps:\/\/doi.org\/10.1155\/2015\/156704\n\n.","journal-title":"BioMed Res Int."},{"key":"5841_CR20","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","volume":"20","author":"JF Lin","year":"2014","unstructured":"Lin JF, Chen JM, Zuo JH, et al. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis.. 2014;20:1407\u20131415. \nhttps:\/\/doi.org\/10.1097\/MIB.0000000000000057\n\n.","journal-title":"Inflamm Bowel Dis."},{"key":"5841_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jpedsurg.2012.02.027","volume":"47","author":"KW Reisinger","year":"2012","unstructured":"Reisinger KW, Van der Zee DC, Brouwers HAA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg.. 2012;47:1640\u20131645. \nhttps:\/\/doi.org\/10.1016\/j.jpedsurg.2012.02.027\n\n.","journal-title":"J Pediatr Surg."},{"key":"5841_CR22","doi-asserted-by":"publisher","first-page":"e58720","DOI":"10.1371\/journal.pone.0058720","volume":"8","author":"T Benkoe","year":"2013","unstructured":"Benkoe T, Baumann S, Weninger M, et al. Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PLoS One.. 2013;8:e58720. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0058720\n\n.","journal-title":"PLoS One."},{"key":"5841_CR23","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/erm.2016.13","volume":"18","author":"SX Cho","year":"2016","unstructured":"Cho SX, Berger PJ, Nold-Petry CA, Nold MF. The immunological landscape in necrotising enterocolitis. Expert Rev Mol Med.. 2016;18:e12. \nhttps:\/\/doi.org\/10.1017\/erm.2016.13\n\n.","journal-title":"Expert Rev Mol Med."},{"key":"5841_CR24","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1097\/MPG.0000000000001588","volume":"65","author":"G Terrin","year":"2017","unstructured":"Terrin G, Stronati L, Cucchiara S, De Curtis M. Serum markers of necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr.. 2017;65:e120\u2013e132. \nhttps:\/\/doi.org\/10.1097\/MPG.0000000000001588\n\n.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"5841_CR25","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.jpedsurg.2014.03.012","volume":"49","author":"TM Benkoe","year":"2014","unstructured":"Benkoe TM, Mechtler TP, Weninger M, Pones M, Rebhandl W, Kasper DC. Serum levels of interleukin-8 and gut-associated biomarkers in diagnosing necrotizing enterocolitis in preterm infants. J Pediatr Surg.. 2014;49:1446\u20131451. \nhttps:\/\/doi.org\/10.1016\/j.jpedsurg.2014.03.012\n\n.","journal-title":"J Pediatr Surg."},{"key":"5841_CR26","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1097\/MPG.0000000000001588","volume":"65","author":"G Terrin","year":"2017","unstructured":"Terrin G, Stronati L, Cucchiara S, De Curtis M. Serum markers of necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr.. 2017;65:e120\u2013e132. \nhttps:\/\/doi.org\/10.1097\/MPG.0000000000001588\n\n.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"5841_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/SLA.0b013e318288ea96","volume":"258","author":"EW Ng","year":"2013","unstructured":"Ng EW, Poon TC, Lam HS, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg.. 2013;258:1111\u20131118. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e318288ea96\n\n.","journal-title":"Ann Surg."},{"key":"5841_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.earlhumdev.2011.05.004","volume":"87","author":"C Aydemir","year":"2011","unstructured":"Aydemir C, Dilli D, Oguz SS, et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev.. 2011;87:659\u2013661. \nhttps:\/\/doi.org\/10.1016\/j.earlhumdev.2011.05.004\n\n.","journal-title":"Early Hum Dev."},{"key":"5841_CR29","doi-asserted-by":"publisher","first-page":"e0121336","DOI":"10.1371\/journal.pone.0121336","volume":"10","author":"M Schurink","year":"2015","unstructured":"Schurink M, Kooi EMW, Hulzebos CV, et al. Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS One.. 2015;10:e0121336. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0121336\n\n.","journal-title":"PLoS One."},{"key":"5841_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jpedsurg.2009.09.024","volume":"45","author":"NJ Evennett","year":"2010","unstructured":"Evennett NJ, Hall NJ, Pierro A, Eaton S. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg.. 2010;45:735\u2013740. \nhttps:\/\/doi.org\/10.1016\/j.jpedsurg.2009.09.024\n\n.","journal-title":"J Pediatr Surg."},{"key":"5841_CR31","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jpedsurg.2014.11.037","volume":"50","author":"FH Heida","year":"2015","unstructured":"Heida FH, Hulscher JBF, Schurink M, et al. Intestinal fatty acid-binding protein levels in Necrotizing Enterocolitis correlate with extent of necrotic bowel: results from a multicenter study. J Pediatr Surg.. 2015;50:1115\u20131118. \nhttps:\/\/doi.org\/10.1016\/j.jpedsurg.2014.11.037\n\n.","journal-title":"J Pediatr Surg."},{"key":"5841_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1056\/NEJMra1503884","volume":"374","author":"DG Clair","year":"2016","unstructured":"Clair DG, Beach JM. Mesenteric Ischemia. N Engl J Med.. 2016;374:959\u2013968. \nhttps:\/\/doi.org\/10.1056\/NEJMra1503884\n\n.","journal-title":"N Engl J Med."},{"key":"5841_CR33","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/acem.12254","volume":"20","author":"MT Cudnik","year":"2013","unstructured":"Cudnik MT, Darbha S, Jones J, Macedo J, Stockton SW, Hiestand BC. The diagnosis of acute mesenteric ischemia: a systematic review and meta-analysis. Acad Emerg Med.. 2013;20:1087\u20131100. \nhttps:\/\/doi.org\/10.1111\/acem.12254\n\n.","journal-title":"Acad Emerg Med."},{"key":"5841_CR34","doi-asserted-by":"publisher","first-page":"e3428","DOI":"10.1371\/journal.pone.0003428","volume":"3","author":"JPM Derikx","year":"2008","unstructured":"Derikx JPM, Matthijsen RA, de Bruine AP, et al. Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One.. 2008;3:e3428. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0003428\n\n.","journal-title":"PLoS One."},{"key":"5841_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MCG.0b013e3182a87e3e","volume":"48","author":"DHSM Schellekens","year":"2014","unstructured":"Schellekens DHSM, Grootjans J, Dello SAWG, et al. Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J Clin Gastroenterol.. 2014;48:253\u2013260. \nhttps:\/\/doi.org\/10.1097\/MCG.0b013e3182a87e3e\n\n.","journal-title":"J Clin Gastroenterol."},{"key":"5841_CR36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.cursur.2006.05.006","volume":"63","author":"DR Cronk","year":"2006","unstructured":"Cronk DR, Houseworth TP, Cuadrado DG, Herbert GS, McNutt PM, Azarow KS. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg.. 2006;63:322\u2013325. \nhttps:\/\/doi.org\/10.1016\/j.cursur.2006.05.006\n\n.","journal-title":"Curr Surg."},{"key":"5841_CR37","doi-asserted-by":"publisher","first-page":"e99915","DOI":"10.1371\/journal.pone.0099915","volume":"9","author":"H Kittaka","year":"2014","unstructured":"Kittaka H, Akimoto H, Takeshita H, et al. Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. PLoS One.. 2014;9:e99915. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0099915\n\n.","journal-title":"PLoS One."},{"key":"5841_CR38","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1007\/s00595-013-0810-3","volume":"44","author":"M Guzel","year":"2014","unstructured":"Guzel M, Sozuer EM, Salt O, Ikizceli I, Akdur O, Yazici C. Value of the serum I-FABP level for diagnosing acute mesenteric ischemia. Surg Today.. 2014;44:2072\u20132076. \nhttps:\/\/doi.org\/10.1007\/s00595-013-0810-3\n\n.","journal-title":"Surg Today."},{"key":"5841_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.clinre.2014.12.005","volume":"39","author":"H Shi","year":"2015","unstructured":"Shi H, Wu B, Wan J, Liu W, Su B. The role of serum intestinal fatty acid binding protein levels and d-lactate levels in the diagnosis of acute intestinal ischemia. Clin Res Hepatol Gastroenterol.. 2015;39:373\u2013378. \nhttps:\/\/doi.org\/10.1016\/j.clinre.2014.12.005\n\n.","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"5841_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/bjs.9331","volume":"101","author":"S Matsumoto","year":"2014","unstructured":"Matsumoto S, Sekine K, Funaoka H, et al. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. Br J Surg. 2014;101:232\u2013238. \nhttps:\/\/doi.org\/10.1002\/bjs.9331\n\n.","journal-title":"Br J Surg"},{"key":"5841_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s00535-011-0373-2","volume":"46","author":"T Kanda","year":"2011","unstructured":"Kanda T, Tsukahara A, Ueki K, et al. Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol.. 2011;46:492\u2013500. \nhttps:\/\/doi.org\/10.1007\/s00535-011-0373-2\n\n.","journal-title":"J Gastroenterol."},{"key":"5841_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2253-14-111","volume":"14","author":"PHJ van der Voort","year":"2014","unstructured":"van der Voort PHJ, Westra B, Wester JPJ, et al. Can serum l-lactate, d-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia. BMC Anesthesiol.. 2014;14:111. \nhttps:\/\/doi.org\/10.1186\/1471-2253-14-111\n\n.","journal-title":"BMC Anesthesiol."},{"key":"5841_CR43","doi-asserted-by":"publisher","first-page":"34371","DOI":"10.1038\/srep34371","volume":"6","author":"DL Sun","year":"2016","unstructured":"Sun DL, Cen YY, Li SM, Li WM, Lu QP, Xu PY. Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis. Sci Rep.. 2016;6:34371. \nhttps:\/\/doi.org\/10.1038\/srep34371\n\n.","journal-title":"Sci Rep."},{"key":"5841_CR44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/SLA.0b013e318207a767","volume":"253","author":"G Thuijls","year":"2011","unstructured":"Thuijls G, van Wijck K, Grootjans J, et al. Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg.. 2011;253:303\u2013308. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e318207a767\n\n.","journal-title":"Ann Surg."},{"key":"5841_CR45","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol.. 2018;16:823\u2013836. \nhttps:\/\/doi.org\/10.1016\/j.cgh.2017.06.037\n\n.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"5841_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"B Lebwohl","year":"2018","unstructured":"Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet.. 2018;391:70\u201381. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(17)31796-8\n\n.","journal-title":"Lancet."},{"key":"5841_CR47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","volume":"11","author":"G Oberhuber","year":"1999","unstructured":"Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol.. 1999;11:1185\u20131194.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"5841_CR48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","volume":"54","author":"S Husby","year":"2012","unstructured":"Husby S, Koletzko S, Korponay-Szabo IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr.. 2012;54:136\u2013160. \nhttps:\/\/doi.org\/10.1097\/MPG.0b013e31821a23d0\n\n.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"5841_CR49","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/apt.12970","volume":"40","author":"R Tortora","year":"2014","unstructured":"Tortora R, Imperatore N, Capone P, et al. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy. Aliment Pharmacol Ther.. 2014;40:1223\u20131229. \nhttps:\/\/doi.org\/10.1111\/apt.12970\n\n.","journal-title":"Aliment Pharmacol Ther."},{"key":"5841_CR50","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s10620-017-4672-1","volume":"62","author":"K Efthymakis","year":"2017","unstructured":"Efthymakis K, Serio M, Milano A, et al. Application of the biopsy-sparing ESPGHAN guidelines for celiac disease diagnosis in adults: a real-life study. Dig Dis Sci.. 2017;62:2433\u20132439. \nhttps:\/\/doi.org\/10.1007\/s10620-017-4672-1\n\n.","journal-title":"Dig Dis Sci."},{"key":"5841_CR51","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/apt.12194","volume":"37","author":"MPM Adriaanse","year":"2013","unstructured":"Adriaanse MPM, Tack GJ, Passos VL, et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther.. 2013;37:482\u2013490. \nhttps:\/\/doi.org\/10.1111\/apt.12194\n\n.","journal-title":"Aliment Pharmacol Ther."},{"key":"5841_CR52","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3109\/00365521.2011.627447","volume":"46","author":"AC Vreugdenhil","year":"2011","unstructured":"Vreugdenhil AC, Wolters VM, Adriaanse MP, et al. Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Scand J Gastroenterol.. 2011;46:1435\u20131441. \nhttps:\/\/doi.org\/10.3109\/00365521.2011.627447\n\n.","journal-title":"Scand J Gastroenterol."},{"key":"5841_CR53","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1038\/s41598-017-07242-4","volume":"7","author":"MPM Adriaanse","year":"2017","unstructured":"Adriaanse MPM, Mubarak A, Riedl RG, et al. Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP. Sci Rep.. 2017;7:8671. \nhttps:\/\/doi.org\/10.1038\/s41598-017-07242-4\n\n.","journal-title":"Sci Rep."},{"key":"5841_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MPG.0000000000001460","volume":"64","author":"MM Leonard","year":"2017","unstructured":"Leonard MM, Weir DC, DeGroote M, et al. Value of IgA tTG in predicting mucosal recovery in children with celiac disease on a gluten-free diet. J Pediatr Gastroenterol Nutr.. 2017;64:286\u2013291. \nhttps:\/\/doi.org\/10.1097\/MPG.0000000000001460\n\n.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"5841_CR55","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/apt.12510","volume":"38","author":"LM Sharkey","year":"2013","unstructured":"Sharkey LM, Corbett G, Currie E, Lee J, Sweeney N, Woodward JM. Optimising delivery of care in coeliac disease\u2014comparison of the benefits of repeat biopsy and serological follow-up. Aliment Pharmacol Ther.. 2013;38:1278\u20131291. \nhttps:\/\/doi.org\/10.1111\/apt.12510\n\n.","journal-title":"Aliment Pharmacol Ther."},{"key":"5841_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-230X-14-28","volume":"14","author":"E Vecsei","year":"2014","unstructured":"Vecsei E, Steinwendner S, Kogler H, et al. Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study. BMC Gastroenterol.. 2014;14:28. \nhttps:\/\/doi.org\/10.1186\/1471-230X-14-28\n\n.","journal-title":"BMC Gastroenterol."},{"key":"5841_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/j.gastro.2017.05.015","volume":"153","author":"JA Silvester","year":"2017","unstructured":"Silvester JA, Kurada S, Szwajcer A, Kelly CP, Leffler DA, Duerksen DR. Tests for serum transglutaminase and endomysial antibodies do not detect most patients with celiac disease and persistent villous atrophy on gluten-free diets: a meta-analysis. Gastroenterology.. 2017;153:689\u2013701. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2017.05.015\n\n.","journal-title":"Gastroenterology."},{"key":"5841_CR58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MPG.0000000000001270","volume":"64","author":"D Gidrewicz","year":"2017","unstructured":"Gidrewicz D, Trevenen CL, Lyon M, Butzner JD. Normalization time of celiac serology in children on a gluten-free diet. J Pediatr Gastroenterol Nutr.. 2017;64:362\u2013367. \nhttps:\/\/doi.org\/10.1097\/MPG.0000000000001270\n\n.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"5841_CR59","first-page":"258","volume":"24","author":"S Gross","year":"2015","unstructured":"Gross S, Adriaanse MP, Nijeboer P, et al. Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease. J Gastrointest Liver Dis JGLD.. 2015;24:258\u2013259.","journal-title":"J Gastrointest Liver Dis JGLD."},{"key":"5841_CR60","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.cgh.2014.07.024","volume":"13","author":"AS Oxentenko","year":"2015","unstructured":"Oxentenko AS, Murray JA. Celiac disease: ten things that every gastroenterologist should know. Clin Gastroenterol Hepatol.. 2015;13:1396\u20131404. \nhttps:\/\/doi.org\/10.1016\/j.cgh.2014.07.024\n\n. quiz e127-9.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"5841_CR61","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/archdischild-2013-303996","volume":"98","author":"S Murch","year":"2013","unstructured":"Murch S, Jenkins H, Auth M, et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child.. 2013;98:806\u2013811. \nhttps:\/\/doi.org\/10.1136\/archdischild-2013-303996\n\n.","journal-title":"Arch Dis Child."},{"key":"5841_CR62","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ajg.2016.162","volume":"111","author":"MPM Adriaanse","year":"2016","unstructured":"Adriaanse MPM, Leffler DA, Kelly CP, et al. Serum I-FABP detects gluten responsiveness in adult celiac disease patients on a short-term gluten challenge. Am J Gastroenterol.. 2016;111:1014\u20131022. \nhttps:\/\/doi.org\/10.1038\/ajg.2016.162\n\n.","journal-title":"Am J Gastroenterol."},{"key":"5841_CR63","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med.. 2009;361:2066\u20132078. \nhttps:\/\/doi.org\/10.1056\/NEJMra0804647\n\n.","journal-title":"N Engl J Med."},{"key":"5841_CR64","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"DC Baumgart","year":"2012","unstructured":"Baumgart DC, Sandborn WJ. Crohn\u2019s disease. Lancet.. 2012;380:1590\u20131605. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(12)60026-9\n\n.","journal-title":"Lancet."},{"key":"5841_CR65","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ibd.21145","volume":"16","author":"J Goodhand","year":"2010","unstructured":"Goodhand J, Dawson R, Hefferon M, et al. Inflammatory bowel disease in young people: the case for transitional clinics. Inflamm Bowel Dis.. 2010;16:947\u2013952. \nhttps:\/\/doi.org\/10.1002\/ibd.21145\n\n.","journal-title":"Inflamm Bowel Dis."},{"key":"5841_CR66","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ibd.23013","volume":"19","author":"A Levine","year":"2013","unstructured":"Levine A, de Bie CI, Turner D, et al. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis.. 2013;19:370\u2013377. \nhttps:\/\/doi.org\/10.1002\/ibd.23013\n\n.","journal-title":"Inflamm Bowel Dis."},{"key":"5841_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7754\/Clin.Lab.2014.140518","volume":"61","author":"M Sarikaya","year":"2015","unstructured":"Sarikaya M, Ergul B, Dogan Z, Filik L, Can M, Arslan L. Intestinal fatty acid binding protein (I-FABP) as a promising test for Crohn\u2019s disease: a preliminary study. Clin Lab.. 2015;61:87\u201391.","journal-title":"Clin Lab."},{"key":"5841_CR68","doi-asserted-by":"publisher","first-page":"1745918","DOI":"10.1155\/2017\/1745918","volume":"2017","author":"AK Al-Saffar","year":"2017","unstructured":"Al-Saffar AK, Meijer CH, Gannavarapu VR, et al. Parallel changes in harvey-bradshaw index, TNFalpha, and intestinal fatty acid binding protein in response to infliximab in crohn\u2019s disease. Gastroenterol Res Pract.. 2017;2017:1745918. \nhttps:\/\/doi.org\/10.1155\/2017\/1745918\n\n.","journal-title":"Gastroenterol Res Pract."},{"key":"5841_CR69","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/MEG.0000000000000616","volume":"28","author":"AGL Bodelier","year":"2016","unstructured":"Bodelier AGL, Pierik MJ, Lenaerts K, et al. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol.. 2016;28:807\u2013813. \nhttps:\/\/doi.org\/10.1097\/MEG.0000000000000616\n\n.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"5841_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.regpep.2007.12.002","volume":"147","author":"A Wiercinska-Drapalo","year":"2008","unstructured":"Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept.. 2008;147:25\u201328. \nhttps:\/\/doi.org\/10.1016\/j.regpep.2007.12.002\n\n.","journal-title":"Regul Pept."},{"key":"5841_CR71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/00365528809101544","volume":"148","author":"S Meyers","year":"1988","unstructured":"Meyers S, Sachar DB, Present DH, Janowitz HD. Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Scand J Gastroenterol Suppl.. 1988;148:29\u201337.","journal-title":"Scand J Gastroenterol Suppl."},{"key":"5841_CR72","doi-asserted-by":"publisher","first-page":"e0138062","DOI":"10.1371\/journal.pone.0138062","volume":"10","author":"MPM Adriaanse","year":"2015","unstructured":"Adriaanse MPM, van der Sande LJTM, van den Neucker AM, et al. Evidence for a cystic fibrosis enteropathy. PLoS One.. 2015;10:e0138062. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0138062\n\n.","journal-title":"PLoS One."},{"key":"5841_CR73","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/annonc\/mdn579","volume":"20","author":"JPM Derikx","year":"2009","unstructured":"Derikx JPM, Blijlevens NMA, Donnelly JP, et al. Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. Ann Oncol Off J Eur Soc Med Oncol.. 2009;20:337\u2013342. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdn579\n\n.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"key":"5841_CR74","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/00007890-200104270-00008","volume":"71","author":"SS Kaufman","year":"2001","unstructured":"Kaufman SS, Lyden ER, Marks WH, et al. Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejection. Transplantation.. 2001;71:1058\u20131060.","journal-title":"Transplantation."},{"key":"5841_CR75","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MEG.0b013e3282f41b82","volume":"20","author":"S Balesaria","year":"2008","unstructured":"Balesaria S, Pell RJ, Abbott LJ, et al. Exploring possible mechanisms for primary bile acid malabsorption: evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea. Eur J Gastroenterol Hepatol.. 2008;20:413\u2013422. \nhttps:\/\/doi.org\/10.1097\/MEG.0b013e3282f41b82\n\n.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"5841_CR76","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1553-2712.2010.00792.x","volume":"17","author":"B Relja","year":"2010","unstructured":"Relja B, Szermutzky M, Henrich D, et al. Intestinal-FABP and liver-FABP: Novel markers for severe abdominal injury. Acad Emerg Med Off J Soc Acad Emerg Med.. 2010;17:729\u2013735. \nhttps:\/\/doi.org\/10.1111\/j.1553-2712.2010.00792.x\n\n.","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med."},{"key":"5841_CR77","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/SHK.0000000000000284","volume":"43","author":"K Timmermans","year":"2015","unstructured":"Timmermans K, Sir O, Kox M, et al. Circulating iFABP Levels as a marker of intestinal damage in trauma patients. Shock (Augusta, Ga).. 2015;43:117\u2013120. \nhttps:\/\/doi.org\/10.1097\/SHK.0000000000000284\n\n.","journal-title":"Shock (Augusta, Ga)."},{"key":"5841_CR78","doi-asserted-by":"publisher","first-page":"e48777","DOI":"10.1371\/journal.pone.0048777","volume":"7","author":"J Shi","year":"2012","unstructured":"Shi J, Zhang Y, Gu W, et al. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults. PLoS One.. 2012;7:e48777. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0048777\n\n.","journal-title":"PLoS One."},{"key":"5841_CR79","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000362497","volume":"106","author":"G Gollin","year":"2014","unstructured":"Gollin G, Stadie D, Mayhew J, et al. Early detection of impending necrotizing enterocolitis with urinary intestinal fatty acid-binding protein. Neonatology.. 2014;106:195\u2013200. \nhttps:\/\/doi.org\/10.1159\/000362497\n\n.","journal-title":"Neonatology."},{"key":"5841_CR80","doi-asserted-by":"publisher","first-page":"5727312","DOI":"10.1155\/2016\/5727312","volume":"2016","author":"S Coufal","year":"2016","unstructured":"Coufal S, Kokesova A, Tlaskalova-Hogenova H, Snajdauf J, Rygl M, Kverka M. Urinary intestinal fatty acid-binding protein can distinguish necrotizing enterocolitis from sepsis in early stage of the disease. J Immunol Res.. 2016;2016:5727312. \nhttps:\/\/doi.org\/10.1155\/2016\/5727312\n\n.","journal-title":"J Immunol Res."},{"key":"5841_CR81","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/SLA.0b013e3181d778c4","volume":"251","author":"G Thuijls","year":"2010","unstructured":"Thuijls G, Derikx JPM, van Wijck K, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg.. 2010;251:1174\u20131180. \nhttps:\/\/doi.org\/10.1097\/SLA.0b013e3181d778c4\n\n.","journal-title":"Ann Surg."},{"key":"5841_CR82","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.jpeds.2014.01.057","volume":"164","author":"KE Gregory","year":"2014","unstructured":"Gregory KE, Winston AB, Yamamoto HS, et al. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. J Pediatr.. 2014;164:1486\u20131488. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2014.01.057\n\n.","journal-title":"J Pediatr."},{"key":"5841_CR83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jpedsurg.2010.09.069","volume":"46","author":"K Mannoia","year":"2011","unstructured":"Mannoia K, Boskovic DS, Slater L, Plank MS, Angeles DM, Gollin G. Necrotizing enterocolitis is associated with neonatal intestinal injury. J Pediatr Surg.. 2011;46:81\u201385. \nhttps:\/\/doi.org\/10.1016\/j.jpedsurg.2010.09.069\n\n.","journal-title":"J Pediatr Surg."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05841-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T23:24:09Z","timestamp":1600125849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05841-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5841"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05841-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"18 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"SSCH is supported by a Freemasons Paediatric Postgraduate Scholarship.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}